Related Experiment Video

Updated: May 17, 2026

Demystifying In Vivo Bioluminescence Imaging of a Chagas Disease Mouse Model for Drug Efficacy Studies
07:59

Demystifying In Vivo Bioluminescence Imaging of a Chagas Disease Mouse Model for Drug Efficacy Studies

Published on: May 31, 2024

Mortality prediction in Chagas heart disease

Maria Carmo Pereira Nunes1, Andre Assis Lopes do Carmo, Manoel Otávio Costa Rocha

  • 1Universidade Federal de Minas Gerais, Belo Horizonte, Brazil. mcarmo@waymail.com.br

Expert Review of Cardiovascular Therapy
|October 27, 2012
PubMed

Insights

Chagas disease causes severe heart conditions like dilated cardiomyopathy. Identifying prognostic markers is crucial for managing Chagas heart disease and predicting patient survival.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Epidemiology

Background:

  • Chagas disease is a significant cause of cardiac morbidity and mortality in Latin America.
  • Dilated cardiomyopathy is the most severe manifestation, leading to heart failure, arrhythmia, and thromboembolism.

Purpose of the Study:

  • To identify prognostic markers for Chagas heart disease progression.
  • To improve risk stratification and patient management strategies.

Main Methods:

  • Review of clinical presentations and prognostic factors in Chagas heart disease.
  • Analysis of established and emerging predictors of mortality.

Main Results:

  • Key predictors of mortality include New York Heart Association functional class, left ventricular systolic dysfunction, and nonsustained ventricular tachycardia.
  • Mortality prediction scores combining prognostic variables enhance risk stratification.

Conclusions:

  • Identifying prognostic markers is vital for managing Chagas heart disease.
  • Risk stratification tools aid in predicting outcomes for affected individuals.

More Related Videos

Sexual Transmission of American Trypanosomes from Males and Females to Naive Mates13:55

Sexual Transmission of American Trypanosomes from Males and Females to Naive Mates

Published on: January 27, 2019

In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase08:48

In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase

Published on: November 5, 2021

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...